LAKESHORE BIOPHARMA CO LTD (LSB) Stock Balance Sheet
USA - NASDAQ:LSB - KYG9845F2080 - Common Stock
0.627 USD
-0.16 (-20.68%)
0.5399 USD
-0.09 (-13.89%)
| 2025 (2025-3-31) | 2024 (2024-3-31) | 2023 (2023-3-31) | 2022 (2021-12-31) | 2021 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 28.08M | 246.35M | 370.11M | 900.00K | 390.46M | |||
| Marketable Securities | 3.28M | 4.04M | 4.34M | 2.81M | 1.36M | |||
| Receivables | 501.79M | 447.15M | 468.09M | 312.74M | 248.01M | |||
| Inventories | 227.59M | 203.42M | 185.38M | 166.51M | 81.44M | |||
| Other Current Assets | 81.47M | 2.20M | 8.06M | 100.00K | 11.94M | |||
| Total Current Assets | 842.22M | 903.17M | 1.04B | 1.00M | 733.20M | |||
| Non-Current Assets | ||||||||
| PPE Net | 414.35M | 480.62M | 582.89M | 565.00M | 253.45M | |||
| Investments And Advances | N/A | N/A | N/A | 200.00M | N/A | |||
| Intangibles | 72.85M | 71.25M | 78.06M | 80.72M | 83.78M | |||
| Other Non-Current Assets | 38.24M | 57.99M | 22.83M | 0.00 | 100.00K | |||
| Total Non-Current Assets | 525.45M | 609.86M | 683.77M | 200.00M | -733.10M | |||
| TOTAL ASSETS | 1.37B | 1.51B | 1.72B | 201.00M | 100.00K | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 390.44M | 318.54M | 193.74M | 111.73M | 0.00 | |||
| Accrued Expenses | 275.51M | 280.83M | 266.17M | 100.00K | 100.00K | |||
| Accounts Payable | 49.55M | 67.77M | 80.44M | 30.81M | 16.38M | |||
| Other Current Liabilities | 109.25M | 135.08M | 118.42M | 105.65M | 60.29M | |||
| Total Current Liabilities | 824.75M | 802.23M | 658.76M | 100.00K | 100.00K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 23.50M | 98.98M | 293.79M | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 19.65M | 26.61M | 38.75M | 20.20M | 44.43M | |||
| Total Non-Current Liabilities | 43.16M | 125.60M | 332.54M | 20.30M | 0.00 | |||
| TOTAL LIABILITIES | 867.91M | 927.82M | 991.30M | 20.40M | 100.00K | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -2.41B | -2.31B | -1.87B | -19.30M | 0.00 | |||
| Additional Paid In Capital | 2.96B | 2.95B | 2.66B | 0.00 | 0.00 | |||
| Common Shares | 28.60K | 26.10K | 12.30K | 200.00M | 0.00 | |||
| Other Shareholders' Equity | -57.27M | -58.18M | -54.41M | 83.09M | 44.22M | |||
| Shares Outstanding | 20.77M | 19.02M | 9.31M | 25.80M | 25.80M | |||
| Tangible Book Value per Share | 20.56 | 27.02 | 69.89 | 7.00 | 0.00 | |||
| Total Shareholders' Equity | 499.75M | 585.21M | 728.45M | 180.70M | 0.00 | |||
| TOTAL LIABILITIES AND EQUITY | 1.37B | 1.51B | 1.72B | 201.00M | 100.00K | |||
| Statistics | ||||||||
| Debt/Equity | 0.05 | 0.17 | 0.40 | N/A | N/A | |||
| Current Ratio | 1.02 | 1.13 | 1.57 | 10.00 | 7332.04 | |||
| Return On Assets (ROA) | -7.31% | -28.65% | -16.48% | -0.27% | N/A | |||
| Return On Equity (ROE) | -20.01% | -74.07% | -38.91% | -0.30% | N/A | |||
All data in CNY , ROIC based on taxRate of 0.21